BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10440909)

  • 1. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y; Wada H; Yamamuro M; Inoue A; Shimura M; Hiyoyama K; Gabazza EC; Isaka N; Shiku H; Takeya H; Suzuki K; Kumeda K; Kato H; Nakano T
    Am J Hematol; 1999 Aug; 61(4):238-42. PubMed ID: 10440909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
    Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
    Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty.
    Mizuno O; Ikeda U; Hojo Y; Fujikawa H; Katsuki T; Shimada K
    Cardiology; 2001; 95(2):84-9. PubMed ID: 11423712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK; Song KS; Park YS; Yun YS; Shim WH
    Cardiology; 2000; 93(1-2):31-6. PubMed ID: 10894904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery.
    Mizuno O; Hojo Y; Ikeda U; Katsuki T; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Am J Cardiol; 2000 Jan; 85(2):154-60. PubMed ID: 10955369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant.
    Wakita Y; Wada H; Nakase T; Nakasaki T; Shimura M; Hiyoyama K; Mori Y; Gabazza EC; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):10-5. PubMed ID: 10725976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
    Farsi A; Domeneghetti MP; Brunelli T; Gori AM; Fedi S; Gensini GF; Giglioli C; Prisco D; Passaleva A; Meroni PL; Del Papa N; Abbate R
    Atherosclerosis; 2001 Feb; 154(2):429-36. PubMed ID: 11166776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
    Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
    Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
    Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M
    Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events.
    Redondo M; Carroll VA; Mauron T; Biasiutti FD; Binder BR; Lämmle B; Wuillemin WA
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):17-24. PubMed ID: 11229822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.